Vor Biopharma earnings were -$116.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest VOR earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$30.7M, up 11.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VOR reported annual earnings of -$116.9M, with -0.8% growth. The next VOR earnings date is May 7, 2025.
On VOR's earnings call on Invalid Date, Vor Biopharma (NASDAQ: VOR) reported Q4 2024 earnings per share (EPS) of -$0.44, up 15.79% year over year. Total VOR earnings for the quarter were -$30.71 million. In the same quarter last year, Vor Biopharma's earnings per share (EPS) was -$0.38.
The next VOR earnings date is Invalid Date. Add VOR to your watchlist to be reminded of Vor Biopharma's next earnings date.
What was VOR's earnings growth in the past year?
As of Vor Biopharma's earnings date in Invalid Date, Vor Biopharma's earnings has grown year over year. VOR earnings in the past year totalled -$116.91 million.
Is Vor Biopharma profitable or losing money?
As of the last Vor Biopharma earnings report, Vor Biopharma is currently losing money. Vor Biopharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$116.91 million, a 0.81% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.